Accessibility StatementSkip Navigation PORT CANAVERAL, Fla., Nov. 30, 2025 /PRNewswire/ --Â Princess Cruises, one of the best-known names in cruising, today marked a major milestone with the arrival of the cruise line's very first Royal-Class ship, Sky Princess, to homeport in Port Canaveral, beginning a season of Caribbean cruises from Central Florida. Continue Reading Princess Cruises' Sky Princess arrived at Cruise Terminal 6 this morning.(Credit: Canaveral Port Authority) Starting today and continuing t ...

Medtronic plc (NYSE:MDT) is included among the 15 Best Boring Dividend Stocks to Buy. Barclays Adjusts Medtronic (MDT) Forecast After Encouraging Earnings Report On November 20, Barclays raised its price targe⁠t on Medtronic plc (NYSE:MDT) to $111 from $109 while maintaining an Overweight rating‌,⁠ following a‍ strong⁠ quarter that exceeded expectations an‌d prompted the fi‌rm to increase its estimates, as reported by The Fly. For the sec⁠ond qua​rter of fiscal 2026, w⁠hich e​nded o⁠n‍ Oc⁠tober 24, Medt ...

American Electric Power Company, Inc. (NASDAQ:AEP) is included among the 15 Best Boring Dividend Stocks to Buy. Morgan Stanley Revises AEP Price Target Following Performance Review On November 20, Mo‍rgan Stanley low‌ered its price t‌arget on American Electric Power Company, Inc. (NASDAQ:AEP) to $128 from $130 while ke‍eping a​n Overweight rating on the stock, according to a report by The Fly. ⁠For⁠ the third qua⁠r​ter of‍ 2025, American Electric Power Company, Inc. (NASDAQ:AEP) reported revenue of $⁠6. ...

Core Insights - Black Friday online sales reached a record $11.8 billion, marking a 9.1% increase year-over-year, exceeding expectations [10][11] - Salesforce is anticipated to report earnings with an EPS of $2.86 and revenue of $10.27 billion, amid concerns about its growth potential and competitive positioning in the AI landscape [3][4] - The stock of Salesforce is currently trading at a historically low valuation, below the S&P 500, which presents a potential buying opportunity due to its predictable business model and AI growth prospects [4] Company Earnings Reports - Salesforce (CRM) is set to report earnings on Wednesday, alongside Snowflake (SNOW), Dollar Tree (DLTR), and C3.ai (AI) [6] - Other companies reporting include MongoDB (MDB) on Monday, and CrowdStrike (CRWD), Marvell (MRVL), and GitLab (GTLB) on Tuesday [5] Economic Indicators - The Federal Reserve is expected to cut rates by a quarter point on December 10, with an 85% probability, influenced by upcoming core PCE inflation figures [8] - Preliminary Michigan sentiment figures for December will provide additional insights into consumer conditions [9] AI and Consumer Behavior - AI traffic to U.S. retail sites surged by 805% year-over-year, indicating a significant shift in consumer behavior as shoppers increasingly utilize generative AI for product research and deal-finding [11] - ChatGPT, celebrating its third anniversary, has seen rapid growth, with projections of 220 million subscribers by 2030 and a valuation reaching $500 billion [12][13]

Core Insights - NextEra Energy, Inc. (NYSE:NEE) is recognized as one of the 15 Best Boring Dividend Stocks to Buy [1] - Morgan Stanley has adjusted its price target for NextEra Energy to $97 from $98 while maintaining an Overweight rating, following a review of the utility sector which underperformed the S&P 500 in October [2] - The International Energy Agency forecasts that AI data centers will consume as much electricity annually as Japan by 2030, presenting a significant growth opportunity for NextEra Energy, which is the largest electricity provider in the U.S. [3] - NextEra Energy has a partnership with Alphabet to restart the Duane Arnold nuclear power plant, expected to generate 615 megawatts of electricity, enough to power hundreds of thousands of homes annually [3] - The company has consistently increased its dividend since 1994, with a 62% increase since 2020, significantly outpacing the 25% inflation rate during the same period [4]

Core Insights - Colgate-Palmolive Company is recognized as one of the 15 Best Boring Dividend Stocks to Buy [1] - Barclays has reduced its price target for Colgate-Palmolive to $80 from $82 while maintaining an Equal Weight rating, highlighting the company's efforts to drive category growth and market share [2] - In Q3 2025, Colgate-Palmolive reported revenue of $5.13 billion, reflecting a 2% increase year-over-year, maintaining a leading position in toothpaste with a 41.2% global market share and 32.4% in manual toothbrushes [2] - The company generated $2.7 billion in operating cash flow during the first nine months of fiscal 2025, with a shift in management focus towards the 2030 Strategy to enhance organizational agility [3] - Colgate-Palmolive's product portfolio includes oral care, personal care, home care, and pet nutrition [4]

Core Insights - Johnson & Johnson (JNJ) plans to acquire Halda Therapeutics for $3.05 billion to enhance its oncology pipeline, particularly in therapies for solid tumors and prostate cancer [2] - This acquisition marks JNJ's second significant transaction in 2023, following a $14.6 billion acquisition of Intra-Cellular Therapies earlier in the year [2] - Halda's leading candidate, HLD-0915, is a prostate cancer therapy in early-to-mid-stage clinical development, with additional candidates targeting various tumor types [3] Financial Performance - In the third quarter, JNJ reported revenue of $15.56 billion from its Innovative Medicine division, surpassing analysts' expectations of $15.42 billion [3] Company Overview - Johnson & Johnson is a global healthcare company involved in the research, development, and production of a wide range of pharmaceuticals and medical technologies [4]

Core Insights - The first week of the year features a comprehensive schedule of earnings reports and economic data [1] Earnings Reports - A variety of companies are expected to release their earnings, providing insights into their financial performance and market conditions [1] Economic Data - Key economic indicators will be released, which may influence market trends and investor sentiment [1]

Core Insights - Gilead Sciences, Inc. (NASDAQ:GILD) is recognized as one of the 15 Best Boring Dividend Stocks to Buy, indicating a stable investment opportunity in the dividend space [1] - Truist initiated coverage of Gilead with a Buy rating and a price target of $140, citing the strength of its HIV portfolio and promising next-generation programs as key factors for a positive long-term outlook [2] - The company's HIV treatment Biktarvy generated $3.7 billion in sales, reflecting a 6% increase year-over-year, while Descovy's revenue rose 20% to $701 million, showcasing robust performance in its core business [3] - Gilead's liver disease treatments also contributed to growth, with sales increasing 12% year-over-year to $819 million, supporting the company's diversification strategy [4] Business Performance - Gilead's underlying business remains solid, with a focus on broadening its portfolio beyond the HIV segment to reduce dependence on it over time [4] - The ongoing strength of the HIV franchise and advancements in oncology efforts are viewed as significant drivers for future growth [2][3]

“Two years later, the car had mechanical problems and the relative quit paying for it.” (Photo subject is a model.) - Getty Images/iStockphoto Dear Quentin, My friend cosigned a loan for a relative to buy a car. The relative had gone through a rough time due to a divorce and needed transportation. Rather than buy a budget car, he bought a 20-year-old BMW with 160,000 miles on it from a dealer, paying too much. It’s my understanding that the defaulter put down $2,000 and my friend cosigned for him to borr ...